Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
- Author:
Hyeonji SEO
1
;
Yong Pil CHONG
Author Information
- Publication Type:Correspondence
- From:Infection and Chemotherapy 2022;54(2):370-371
- CountryRepublic of Korea
- Language:English
